Neumora Therapeutics, Inc. - NMRA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A K2 HealthVentures Equity Trust LLC 3.1% 5,790,453 View
May 15, 2026 SCHEDULE 13G/A Parag Shah 3.1% 5,790,453 View
May 15, 2026 SCHEDULE 13G/A Anup Arora 3.1% 5,790,453 View
May 04, 2026 SCHEDULE 13G/A Invus Public Equities, L.P. 4.3% 7,740,030 View
May 04, 2026 SCHEDULE 13G/A Invus Public Equities Advisors, LLC 4.3% 7,740,030 View
May 04, 2026 SCHEDULE 13G/A Invus Global Management, LLC 4.3% 7,740,030 View
May 04, 2026 SCHEDULE 13G/A Siren, L.L.C. 4.3% 7,740,030 View
May 04, 2026 SCHEDULE 13G/A Avicenna Life Sci Master Fund LP 0.4% 757,792 View
May 04, 2026 SCHEDULE 13G/A Avicenna Life Sci Master GP LLC 0.4% 757,792 View
May 04, 2026 SCHEDULE 13G/A Ulys, L.L.C. 0.4% 757,792 View
May 04, 2026 SCHEDULE 13G/A Raymond Debbane 4.7% 8,497,822 View
Apr 01, 2026 SCHEDULE 13D/A — — — View
Feb 19, 2026 SCHEDULE 13G Invus Public Equities, L.P. 4.9% 8,172,814 View
Feb 19, 2026 SCHEDULE 13G Invus Public Equities Advisors, LLC 4.9% 8,172,814 View
Feb 19, 2026 SCHEDULE 13G Invus Global Management, LLC 4.9% 8,172,814 View
Feb 19, 2026 SCHEDULE 13G Siren, L.L.C. 4.9% 8,172,814 View
Feb 19, 2026 SCHEDULE 13G Avicenna Life Sci Master Fund LP 0.5% 825,008 View
Feb 19, 2026 SCHEDULE 13G Avicenna Life Sci Master GP LLC 0.5% 825,008 View
Feb 19, 2026 SCHEDULE 13G Ulys, L.L.C. 0.5% 825,008 View
Feb 19, 2026 SCHEDULE 13G Raymond Debbane 5.4% 8,997,822 View
Feb 17, 2026 SCHEDULE 13G/A K2 HealthVentures Equity Trust LLC 5.01% 8,997,035 View
Feb 17, 2026 SCHEDULE 13G/A Parag Shah 5.01% 8,997,035 View
Feb 17, 2026 SCHEDULE 13G/A Anup Arora 5.01% 8,997,035 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.